Skip to main content

Post-IPO Equity Biotechnology Companies

Explore 481 biotechnology startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
481
Total Funding
$2.1B
Avg Funding
$85.9M
Cities
19

Export 481 Post-IPO Equity Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Princeton, United States
$3.9M
raised

Sonnet BioTherapeutics is a biotechnology company for innovating biologic drugs of the single or bispecific mechanism of action.

Dec 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Diego, United States
$50.3M
raised

Skye Bioscience is a pharmaceutical company developing new therapeutic outcomes for diseases.

Jan 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Minnesota City, United States
$9.0M
raised

Panbela Therapeutics develops small molecule pharmaceuticals for the oncology and acute care markets.

Jan 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$287.5M
raised

89bio is a biopharmaceutical company that develops clinical-stage therapies for liver and cardiometabolic diseases.

Jan 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Zürich, Switzerland
$5.4M
raised

Xlife Sciences focuses on the performance and growth of life science technologies.

Jan 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 481 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Boston, United States
$125.0M
raised

Pear Therapeutics is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals.

Dec 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$172.5M
raised

Tourmaline Bio is a biotechnology company that develops medicines to treat inflammatory and immune diseases in patients.

Jan 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Diego, United States
$15.0M
raised

Effector Therapeutics is an early-stage company focused on the discovery and development of small molecule cancer therapeutics.

Jan 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$75.0M
raised

Protara Therapeutics develops transformative therapies for people with cancer and rare diseases with limited treatment options.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Rockville, United States
$185.0M
raised

Crescent Biopharma is a biotechnology firm focused on developing novel precision-engineered medicines.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 481 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
La Jolla, United States
$150.0M
raised

Kura Oncology, a biopharmaceutical company, advances a pipeline of precision medicines for the treatment of solid tumors and blood cancers.

Jan 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Stamford, United States
$275.0M
raised

SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.

Dec 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$287.5M
raised

Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.

Jan 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Carlos, United States
$2.8M
raised

Apexigen is a clinical-stage biopharmaceutical company focused on discovering and developing a new antibody therapeutics for oncology.

Jan 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Calgary, Canada
$886K
raised

Onco-Innovations is a biotech business that develops and commercializes medicines for various cancers.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 481 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Menlo Park, United States
$11.2M
raised

Revelation Biosciences develops immunologic therapeutics and diagnostics designed to make the world a healthier place.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

La Jolla, United States
$350.0M
raised

Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.

Dec 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Oslo, Norway
$13.1M
raised

EXACT Therapeutics is a clinical stage biotech firm developing a technology platform for therapeutic enhancement Acoustic Cluster Therapy.

Dec 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$250K
raised

Better Therapeutics develops prescription software for treating cardiometabolic diseases.

Jan 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$10.0M
raised

Intelligent Bio Solutions leverages the power of technology to develop transformative, accurate solutions that improve quality of life.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 481 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Carlsbad, United States
$75.0M
raised

Pardes Biosciences is a biotechnology company that develops and commercializes direct-acting antivirals for the treatment of coronavirus.

Dec 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Waltham, United States
$30.0M
raised

TScan Therapeutics is a biopharmaceutical company focused on the development of immunotherapy treatments for cancer.

Dec 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Charlotte, United States
$1.7M
raised

Adaptin Bio is a pioneering biotechnology business focused to transforming medicine delivery.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Diego, United States

Longboard Pharmaceuticals delivers medicines with optimized pharmacology and pharmacokinetics to patients with rare neurological diseases.

Jan 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Chesterland, United States
$10.7M
raised

Novaccess Global brings together technological assets, scientific, and executive team to accelerate taking these assets to market.

Jan 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 351 to 375 of 481 companies

Ready to Connect with Post-IPO Equity Biotechnology Startups?

Get verified founder emails, funding details, and company data for 481 post-ipo equity biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

481 Biotechnology Post-IPO Equity Startups (September 2026) — Page 15 | VCBacked